Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 183.71 million. The enterprise value is 210.24 million.

Market Cap	183.71M
Enterprise Value	210.24M

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.33 million shares outstanding. The number of shares has increased by 41.82% in one year.

Current Share Class	72.33M
Shares Outstanding	72.33M
Shares Change (YoY)	+41.82%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	12.77%
Float	38.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.40
PB Ratio	2.22
P/TBV Ratio	2.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.18
EV / Sales	3.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.98

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.94.

Current Ratio	1.38
Quick Ratio	0.53
Debt / Equity	0.94
Debt / EBITDA	n/a
Debt / FCF	-2.57
Interest Coverage	-5.80

Financial Efficiency

Return on equity (ROE) is -48.02% and return on invested capital (ROIC) is -13.26%.

Return on Equity (ROE)	-48.02%
Return on Assets (ROA)	-7.43%
Return on Invested Capital (ROIC)	-13.26%
Return on Capital Employed (ROCE)	-24.24%
Revenue Per Employee	246,655
Profits Per Employee	-229,388
Employee Count	222
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, Cellectis has paid 387,433 in taxes.

Income Tax	387,433
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.90% in the last 52 weeks. The beta is 3.06, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	3.06
52-Week Price Change	+41.90%
50-Day Moving Average	1.73
200-Day Moving Average	1.55
Relative Strength Index (RSI)	62.97
Average Volume (20 Days)	570,415

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 54.02 million and -50.24 million in losses. Loss per share was -0.51.

Revenue	54.02M
Gross Profit	54.02M
Operating Income	-38.50M
Pretax Income	-49.85M
Net Income	-50.24M
EBITDA	-28.13M
EBIT	-38.50M
Loss Per Share	-0.51

Full Income Statement

Balance Sheet

The company has 50.93 million in cash and 77.46 million in debt, giving a net cash position of -26.53 million or -0.37 per share.

Cash & Cash Equivalents	50.93M
Total Debt	77.46M
Net Cash	-26.53M
Net Cash Per Share	-0.37
Equity (Book Value)	82.69M
Book Value Per Share	1.14
Working Capital	53.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.39 million and capital expenditures -1.73 million, giving a free cash flow of -30.12 million.

Operating Cash Flow	-28.39M
Capital Expenditures	-1.73M
Free Cash Flow	-30.12M
FCF Per Share	-0.42

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -71.28% and -93.00%.

Gross Margin	100.00%
Operating Margin	-71.28%
Pretax Margin	-92.28%
Profit Margin	-93.00%
EBITDA Margin	-52.08%
EBIT Margin	-71.28%
FCF Margin	n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.82%
Shareholder Yield	n/a
Earnings Yield	-27.35%
FCF Yield	-16.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.95
Piotroski F-Score	3